RecruitingNot ApplicableNCT07446088
Electric Stimulation Home Use(CGM MEPC_2401) for Improving Blood Circulation
A Single-center, Open-label, Exploratory Clinical Trial to Evaluate the Safety and Efficacy of a Statics Electricity Generator for Electric Stimulation Home Use(CGM MEPC_2401) for Improving Blood Circulation
Sponsor
Ceragem Clinical Inc.
Enrollment
40 participants
Start Date
Dec 1, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
This study is a single-center, open-label, exploratory clinical trial to evaluate the safety and efficacy of a statics electricity generator for improving blood circulation.
Eligibility
Min Age: 19 YearsMax Age: 65 Years
Inclusion Criteria3
- Adults aged between 19 and 65 years
- Individuals with a BMI of 30.0 kg/m² or less
- Individuals without abnormal findings on hematology tests (CBC)
Exclusion Criteria4
- Patients with uncontrolled hypertension despite medication (defined as systolic blood pressure ≥150 mmHg or diastolic blood pressure ≥100 mmHg measured at rest)
- Patients with medical conditions requiring the use of assistive devices (e.g., pacemaker, artificial joint, stent, prosthesis, etc.)
- Patients with seizure disorders or a history of loss of consciousness (e.g., epilepsy, acute febrile convulsions such as those associated with severe fever, etc.), or those at high risk of electric shock due to such conditions
- Patients with ventricular arrhythmias (e.g., ventricular tachycardia, history of coronary artery bypass surgery, etc.) and patients with neurological disorders (e.g., diabetic neuropathy, etc.)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICECERAGEM CELLTRON CIRCULATION CHAIR (CGM MEPC-2401)
Improving blood circulation device (Ceragem Celltron Circulation Chair)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07446088